Ganoderma lucidum spores for treatment of autoimmune diseases

Details Ganoderma lucidum spores for treatment of autoimmune diseases Ganoderma lucidum spores for treatment of autoimmune diseases

A - Human Necessities

61

K

A61K 31/573 (2006.01) A61K 31/57 (2006.01) A61P 1/04 (2006.01) A61P 1/16 (2006.01) A61P 3/10 (2006.01) A61P 7/06 (2006.01) A61P 9/10 (2006.01) A61P 13/12 (2006.01) A61P 17/06 (2006.01) A61P 19/02 (2006.01) A61P 21/02 (2006.01) A61P 21/04 (2006.01) A61P 25/00 (2006.01) A61P 29/00 (2006.01) A61P 31/18 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) A61P 37/02 (2006.01) A61P 37/04 (2006.01) A61P 37/06 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2437690

The present invention provides a method for treating a mammal with immunological disorders, particularly autoimmune disease, and most preferably systemic lupus erythematosus (SLE). The method includes oral administration of germination activated Ganoderma lucidum spores ("GLSs") to the mammal. Additionally, a corticosteroid, such as prednisolone, can be co-administered with the GLSs to the mammal to achieve synergistic effect of treatment.

Affiliated with

Also associated with

Rating

Ganoderma lucidum spores for treatment of autoimmune diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ganoderma lucidum spores for treatment of autoimmune diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ganoderma lucidum spores for treatment of autoimmune diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1740643